Active Ingredient(s): Glycopyrronium Tosylate
FDA Approved: * June 28, 2018
Pharm Company: * DERMIRA INC
Category: Anticholinergic

Glycopyrronium bromide is a medication of the muscarinic anticholinergic group. It does not cross the blood–brain barrier and consequently has few to no central effects. It is available in oral, intravenous, topical, and inhaled forms. It is a synthetic quaternary ammonium compound. The cation, which is the active moiety, is called glycopyrronium (INN)[1] or glycopyrrolate (USAN). In June 2018, glycopyrronium was approved by the FDA to treat excessive underarm sweating,... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Qbrexza 2.4 g/100g Topical Cloth
NDC: 69489-411
Journey Medical Corporation
Qbrexza 2.4 g/100g Topical Cloth
NDC: 70428-011
Dermira, Inc.